Fig. 3From: Trabectedin for inoperable or recurrent soft tissue sarcoma in adult patients: a retrospective cohort studyDistribution of best type of response to trabectedin according to tumor histology. Best response was assessed using Response Evaluation Criteria in Solid Tumors (RECIST) (n = 71)Back to article page